Lumigan and Otitis - a phase IV clinical study of FDA data

Summary:

Otitis is reported as a side effect among people who take Lumigan (bimatoprost), especially for people who are female, 60+ old, also take Gabapentin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Otitis when taking Lumigan. It is created by eHealthMe based on reports of 20,141 people who have side effects when taking Lumigan from the FDA, and is updated regularly.

What is Lumigan?

Lumigan has active ingredients of bimatoprost. It is often used in glaucoma. eHealthMe is studying from 20,478 Lumigan users. Check the latest studies of Lumigan.

What is Otitis?

Otitis (ear infection) is found to be associated with 1,409 drugs and 1,837 conditions by eHealthMe. Check the latest studies of Otitis.

On Aug, 09, 2026

20,141 people reported to have side effects when taking Lumigan.
Among them, 33 people (0.16%) have Otitis.

Among these 33 people:

What is the gender of people who have Otitis when taking Lumigan? *

female: 100 %
male: 0.0 %

What is the age of people who have Otitis when taking Lumigan? *

What are other drugs people take besides Lumigan? *

Gabapentin: 13 people, 39.39%
Meclizine Hydrochloride: 12 people, 36.36%
Hydroxyzine: 11 people, 33.33%
Topiramate: 10 people, 30.30%
Tylenol: 10 people, 30.30%
Cymbalta: 10 people, 30.30%
Norvasc: 9 people, 27.27%
Proair Hfa: 8 people, 24.24%
Symbicort: 8 people, 24.24%
Vitamin D: 8 people, 24.24%

What are other side effects people have besides Otitis? *

Sinusitis (inflammation of sinus): 17 people, 51.52%
Headache (pain in head): 14 people, 42.42%
Pain: 11 people, 33.33%
Gait Disturbance: 11 people, 33.33%
Tooth Abscess (pus formation in tooth): 11 people, 33.33%
Dyspnea (difficult or laboured breathing): 11 people, 33.33%
Chest Pain: 10 people, 30.30%
Chills (felling of cold): 10 people, 30.30%
Weakness: 10 people, 30.30%
Fever: 10 people, 30.30%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 7 people, 21.21%
Asthma: 6 people, 18.18%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 18.18%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 15.15%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 9.09%
Depression: 3 people, 9.09%
Pain: 2 people, 6.06%
Intraocular Pressure Increased: 2 people, 6.06%
Fatigue (feeling of tiredness): 1 person, 3.03%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Lumigan and have Otitis?

- Check whether Otitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lumigan:

Lumigan (20,478 reports)

Otitis treatments and more:

Otitis (36,446 reports)

Browse all side effects of Lumigan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Otitis:

Otitis (1,409 drugs)

Browse all the conditions that are associated with Otitis:

Otitis (1,837 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bimatoprost (the active ingredients of Lumigan) and Lumigan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.